CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice

Michele Doucet, Swaathi Jayaraman, Emily Swenson, Brittany Tusing, Kristy L. Weber, Scott L. Kominsky

Research output: Research - peer-reviewArticle

Abstract

CCL20 is a member of the macrophage inflammatory protein family and is reported to signal monogamously through the receptor CCR6. Although studies have identified the genomic locations of both Ccl20 and Ccr6 as regions important for bone quality, the role of CCL20/CCR6 signaling in regulating bone mass is unknown. By micro–computed tomography (μCT) and histomorphometric analysis, we show that global loss of Ccr6 in mice significantly decreases trabecular bone mass coincident with reduced osteoblast numbers. Notably, CCL20 and CCR6 were co-expressed in osteoblast progenitors and levels increased during osteoblast differentiation, indicating the potential of CCL20/CCR6 signaling to influence osteoblasts through both autocrine and paracrine actions. With respect to autocrine effects, CCR6 was found to act as a functional G protein–coupled receptor in osteoblasts and although its loss did not appear to affect the number or proliferation rate of osteoblast progenitors, differentiation was significantly inhibited as evidenced by delays in osteoblast marker gene expression, alkaline phosphatase activity, and mineralization. In addition, CCL20 promoted osteoblast survival concordant with activation of the PI3K-AKT pathway. Beyond these potential autocrine effects, osteoblast-derived CCL20 stimulated the recruitment of macrophages and T cells, known facilitators of osteoblast differentiation and survival. Finally, we generated mice harboring a global deletion of Ccl20 and found that Ccl20-/- mice exhibit a reduction in bone mass similar to that observed in Ccr6-/- mice, confirming that this phenomenon is regulated by CCL20 rather than alternate CCR6 ligands. Collectively, these data indicate that CCL20/CCR6 signaling may play an important role in regulating bone mass accrual, potentially by modulating osteoblast maturation, survival, and the recruitment of osteoblast-supporting cells.

LanguageEnglish (US)
Pages1381-1390
Number of pages10
JournalJournal of Bone and Mineral Research
Volume31
Issue number7
DOIs
StatePublished - Jul 1 2016

Fingerprint

Osteoblasts
Bone and Bones
CCR6 Receptors
Macrophage Inflammatory Proteins
G-Protein-Coupled Receptors
Phosphatidylinositol 3-Kinases
Alkaline Phosphatase
Macrophages
Tomography
Ligands
T-Lymphocytes
Gene Expression
Cancellous Bone

Keywords

  • BONE MODELING AND REMODELING
  • CELL/TISSUE SIGNALING
  • CYTOKINES
  • OSTEOBLAST

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Doucet, M., Jayaraman, S., Swenson, E., Tusing, B., Weber, K. L., & Kominsky, S. L. (2016). CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice. Journal of Bone and Mineral Research, 31(7), 1381-1390. DOI: 10.1002/jbmr.2813

CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice. / Doucet, Michele; Jayaraman, Swaathi; Swenson, Emily; Tusing, Brittany; Weber, Kristy L.; Kominsky, Scott L.

In: Journal of Bone and Mineral Research, Vol. 31, No. 7, 01.07.2016, p. 1381-1390.

Research output: Research - peer-reviewArticle

Doucet, M, Jayaraman, S, Swenson, E, Tusing, B, Weber, KL & Kominsky, SL 2016, 'CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice' Journal of Bone and Mineral Research, vol 31, no. 7, pp. 1381-1390. DOI: 10.1002/jbmr.2813
Doucet M, Jayaraman S, Swenson E, Tusing B, Weber KL, Kominsky SL. CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice. Journal of Bone and Mineral Research. 2016 Jul 1;31(7):1381-1390. Available from, DOI: 10.1002/jbmr.2813
Doucet, Michele ; Jayaraman, Swaathi ; Swenson, Emily ; Tusing, Brittany ; Weber, Kristy L. ; Kominsky, Scott L./ CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice. In: Journal of Bone and Mineral Research. 2016 ; Vol. 31, No. 7. pp. 1381-1390
@article{e1cc5156b48c445c96d5327ecaba2396,
title = "CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice",
abstract = "CCL20 is a member of the macrophage inflammatory protein family and is reported to signal monogamously through the receptor CCR6. Although studies have identified the genomic locations of both Ccl20 and Ccr6 as regions important for bone quality, the role of CCL20/CCR6 signaling in regulating bone mass is unknown. By micro–computed tomography (μCT) and histomorphometric analysis, we show that global loss of Ccr6 in mice significantly decreases trabecular bone mass coincident with reduced osteoblast numbers. Notably, CCL20 and CCR6 were co-expressed in osteoblast progenitors and levels increased during osteoblast differentiation, indicating the potential of CCL20/CCR6 signaling to influence osteoblasts through both autocrine and paracrine actions. With respect to autocrine effects, CCR6 was found to act as a functional G protein–coupled receptor in osteoblasts and although its loss did not appear to affect the number or proliferation rate of osteoblast progenitors, differentiation was significantly inhibited as evidenced by delays in osteoblast marker gene expression, alkaline phosphatase activity, and mineralization. In addition, CCL20 promoted osteoblast survival concordant with activation of the PI3K-AKT pathway. Beyond these potential autocrine effects, osteoblast-derived CCL20 stimulated the recruitment of macrophages and T cells, known facilitators of osteoblast differentiation and survival. Finally, we generated mice harboring a global deletion of Ccl20 and found that Ccl20-/- mice exhibit a reduction in bone mass similar to that observed in Ccr6-/- mice, confirming that this phenomenon is regulated by CCL20 rather than alternate CCR6 ligands. Collectively, these data indicate that CCL20/CCR6 signaling may play an important role in regulating bone mass accrual, potentially by modulating osteoblast maturation, survival, and the recruitment of osteoblast-supporting cells.",
keywords = "BONE MODELING AND REMODELING, CELL/TISSUE SIGNALING, CYTOKINES, OSTEOBLAST",
author = "Michele Doucet and Swaathi Jayaraman and Emily Swenson and Brittany Tusing and Weber, {Kristy L.} and Kominsky, {Scott L.}",
year = "2016",
month = "7",
doi = "10.1002/jbmr.2813",
volume = "31",
pages = "1381--1390",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice

AU - Doucet,Michele

AU - Jayaraman,Swaathi

AU - Swenson,Emily

AU - Tusing,Brittany

AU - Weber,Kristy L.

AU - Kominsky,Scott L.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - CCL20 is a member of the macrophage inflammatory protein family and is reported to signal monogamously through the receptor CCR6. Although studies have identified the genomic locations of both Ccl20 and Ccr6 as regions important for bone quality, the role of CCL20/CCR6 signaling in regulating bone mass is unknown. By micro–computed tomography (μCT) and histomorphometric analysis, we show that global loss of Ccr6 in mice significantly decreases trabecular bone mass coincident with reduced osteoblast numbers. Notably, CCL20 and CCR6 were co-expressed in osteoblast progenitors and levels increased during osteoblast differentiation, indicating the potential of CCL20/CCR6 signaling to influence osteoblasts through both autocrine and paracrine actions. With respect to autocrine effects, CCR6 was found to act as a functional G protein–coupled receptor in osteoblasts and although its loss did not appear to affect the number or proliferation rate of osteoblast progenitors, differentiation was significantly inhibited as evidenced by delays in osteoblast marker gene expression, alkaline phosphatase activity, and mineralization. In addition, CCL20 promoted osteoblast survival concordant with activation of the PI3K-AKT pathway. Beyond these potential autocrine effects, osteoblast-derived CCL20 stimulated the recruitment of macrophages and T cells, known facilitators of osteoblast differentiation and survival. Finally, we generated mice harboring a global deletion of Ccl20 and found that Ccl20-/- mice exhibit a reduction in bone mass similar to that observed in Ccr6-/- mice, confirming that this phenomenon is regulated by CCL20 rather than alternate CCR6 ligands. Collectively, these data indicate that CCL20/CCR6 signaling may play an important role in regulating bone mass accrual, potentially by modulating osteoblast maturation, survival, and the recruitment of osteoblast-supporting cells.

AB - CCL20 is a member of the macrophage inflammatory protein family and is reported to signal monogamously through the receptor CCR6. Although studies have identified the genomic locations of both Ccl20 and Ccr6 as regions important for bone quality, the role of CCL20/CCR6 signaling in regulating bone mass is unknown. By micro–computed tomography (μCT) and histomorphometric analysis, we show that global loss of Ccr6 in mice significantly decreases trabecular bone mass coincident with reduced osteoblast numbers. Notably, CCL20 and CCR6 were co-expressed in osteoblast progenitors and levels increased during osteoblast differentiation, indicating the potential of CCL20/CCR6 signaling to influence osteoblasts through both autocrine and paracrine actions. With respect to autocrine effects, CCR6 was found to act as a functional G protein–coupled receptor in osteoblasts and although its loss did not appear to affect the number or proliferation rate of osteoblast progenitors, differentiation was significantly inhibited as evidenced by delays in osteoblast marker gene expression, alkaline phosphatase activity, and mineralization. In addition, CCL20 promoted osteoblast survival concordant with activation of the PI3K-AKT pathway. Beyond these potential autocrine effects, osteoblast-derived CCL20 stimulated the recruitment of macrophages and T cells, known facilitators of osteoblast differentiation and survival. Finally, we generated mice harboring a global deletion of Ccl20 and found that Ccl20-/- mice exhibit a reduction in bone mass similar to that observed in Ccr6-/- mice, confirming that this phenomenon is regulated by CCL20 rather than alternate CCR6 ligands. Collectively, these data indicate that CCL20/CCR6 signaling may play an important role in regulating bone mass accrual, potentially by modulating osteoblast maturation, survival, and the recruitment of osteoblast-supporting cells.

KW - BONE MODELING AND REMODELING

KW - CELL/TISSUE SIGNALING

KW - CYTOKINES

KW - OSTEOBLAST

UR - http://www.scopus.com/inward/record.url?scp=84977596379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977596379&partnerID=8YFLogxK

U2 - 10.1002/jbmr.2813

DO - 10.1002/jbmr.2813

M3 - Article

VL - 31

SP - 1381

EP - 1390

JO - Journal of Bone and Mineral Research

T2 - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 7

ER -